Data Protection Statement for Vigilance

Data protection information on processing personal data related to adverse reactions or events associated with the use of medicinal products and safety of medical devices (vigilance)

Last updated July 2022, previous version

In our capacity as a manufacturer of pharmaceuticals and medical devices, Fresenius Kabi Egypt  (“we”) will collect, use and report personal data of patients using our products and of reporters of adverse reactions or events.

This data protection statement informs you about the processing of personal data when making an adverse event report.

Please be aware that we also may process your personal data in other contexts, e.g. when you visit our website, when you are a business contact for products or services, when you interact with us in your capacity as a healthcare professional or if you submit a data subject request. Please see the specific information on the processing of your personal data in such situations.